Browsing by 저자 : 최창민
전체 결과 37건 중 1-37 번을 표시중입니다.
- 1 Article A Pilot Study of Whether the Cold-Heat Syndrome Type is Associated with Treatment Response and Immune Status in Patients with Non-Small Cell Lung Cancer 최창민 ; Mi-Kyung Jeong ; Ojin Kwon ; et al 2021
- 2 Article Active Treatment Improves Overall Survival in Extremely Older Non-Small Cell Lung Cancer Patients: A Multicenter Retrospective Cohort Study 이재철 ; 최창민 ; Su Yeon Lee ; et al 2021
- 3 Article Active Treatment Improves Overall Survival in Extremely Older Non-Small Cell Lung Cancer Patients: A Multicenter Retrospective Cohort Study 이재철 ; 최창민 ; Su Yeon Lee ; et al 2021
-
4
Dissertation
ALK 양성 폐선암 환자에서 ALK 억제제의 효과에 대한 현실 데이터 연구
김연주
2018
- 5 Article An Attention Model With Transfer Embeddings to Classify Pneumonia-Related Bilingual Imaging Reports: Algorithm Development and Validation 최창민 ; Bo Kyung Seo ; Eun Byul Lee ; et al 2021
- 6 Article Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients 김형렬 ; 최창민 ; Chaeuk Chung ; et al 2021
- 7 Article Characteristics of female lung cancer in Korea: analysis of Korean National Lung Cancer Registry 김호철 ; 최창민 ; Chan Kwon Park ; et al 2020
- 8 Article Clinical Applications of Liquid Biopsy in Non-Small Cell Lung Cancer Patients: Current Status and Recent Advances in Clinical Practice 이재철 ; 최창민 ; Shinhee Park 2021
- 9 Article Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting 김호철 ; 최창민 ; Chan Kwon Park ; et al 2021
- 10 Article Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease 김상위 ; 김수한 ; 김우성 ; et al 2020
- 11 Article Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 노진경 ; 이재철 ; 최창민 ; et al 2021
- 12 Article Diagnostic Performance of Electromagnetic Navigation Bronchoscopy-Guided Biopsy for Lung Nodules in the Era of Molecular Testing 김미영 ; 오상영 ; 장세진 ; et al 2021
- 13 Article Diagnostic yield and safety of biopsy guided by electromagnetic navigation bronchoscopy for high-risk pulmonary nodules 김미영 ; 김우성 ; 오상영 ; et al 2021
- 14 Article Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study 김상위 ; 김우성 ; 윤신교 ; et al 2021
- 15 Article Discovery of a novel CDK7 inhibitor YPN-005 in small cell lung cancer 최윤정 ; 이현정 ; 김다솜 ; et al 2021
- 16 Article Efficacy of the CDK7 inhibitor on EMT-associated resistance to 3rd generation EGFR-TKIs in non-small cell lung cancer cell lines 지원준 ; 최윤정 ; 강명희 ; et al 2020
- 17 Article Establishment and Long-Term Expansion of Small Cell Lung Cancer Patient-Derived Tumor Organoids 최선영 ; 조용희 ; 김다솜 ; et al 2021
- 18 Article Establishment and Long-Term Expansion of Small Cell Lung Cancer Patient-Derived Tumor Organoids 최선영 ; 조용희 ; 김다솜 ; et al 2021
- 19 Article Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2 김동하 ; 박효정 ; 최윤정 ; et al 2021
- 20 Article Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors 원상은 ; 박효정 ; 변상일 ; et al 2020
- 21 Article Lung Cancer in Korea 송시열 ; 최창민 ; Ho Yun Lee ; et al 2021
- 22 Article Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer 조용희 ; 최명근 ; 김동하 ; et al 2020
- 23 Article Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung 김상위 ; 김우성 ; 윤신교 ; et al 2021
- 24 Article Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis 김상위 ; 김우성 ; 윤신교 ; et al 2020
- 25 Article Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A 이재철 ; 최창민 ; Cheol-Kyu Park ; et al 2021
- 26 Article Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A 이재철 ; 최창민 ; Cheol-Kyu Park ; et al 2021
- 27 Article Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy 최창민 ; Chang Dong Yeo ; Hye Seon Kang ; et al 2021
- 28 Article Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population 김형렬 ; 김호철 ; 송시열 ; et al 2021
- 29 Article Prognostic Significance of CHIP and RIPK3 in Non-Small Cell Lung Cancer Jisup Kim ; Joon-Yong Chung ; 박영수 ; et al 2020
- 30 Article Recent Trends of Lung Cancer in Korea 김호철 ; 최창민 ; Jae Guk Lee 2021
- 31 Article Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea 최창민 ; Chan Kwon Park ; Cheol-Kyu Park ; et al 2021
- 32 Article The Effects of Simultaneous Pulmonary Rehabilitation during Thoracic Radiotherapy in the Treatment of Malignant Diseases 김수산 ; 김원 ; 송시열 ; et al 2021
- 33 Article Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum-based doublet chemotherapy and immunotherapy (SPACE study) 최창민 ; Cheol-Kyu Park ; Seung Hyeun Lee ; et al 2021
- 34 Article Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4 김동하 ; 박소정 ; 김형렬 ; et al 2020
-
35
Dissertation
Tumor-derived exosomes promote tumor growth through the modulation of RCAN1.4
박소정
2018
-
36
dissertation
비소세포폐암 환자에서 액체생검을 통한 EGFR 유전자변이 검출의 유용성 확인에 대한 연구
김연주
2022
-
37
Dissertation
비소세포폐암에서 EMT관련 EGFR 표적치료 내성 극복을 위한 CDK7 억제제의 적용
지원준
2019
1